Norris Medicines has informed that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 to consider and approve Un-Audited Financial Results For the Quarter and half year ended September 30th, 2026 And Other Matters.
The above information is a part of company’s filings submitted to BSE.